Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
IMMB stock price ended at $0 on 星期四, after rising NaN%
On the latest trading day Jan 22, 2026, the stock price of IMMB rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 782 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 1.0K shares were traded, equating to a market value of approximately --.